ConductScience.org, home

Paper40366385

Effects of SGLT2 inhibitors on ion channels in heart failure: focus on the endothelium.

Wang M and 3 others. Basic Res Cardiol, 2025. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Effects of SGLT2 inhibitors on ion channels in heart failure: focus on the endothelium. Papers, record 40366385. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40366385

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of SGLT2 inhibitors on ion channels in heart failure: focus on the endothelium.
PubMed
Journal
Basic Res Cardiol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
4.23, provisional
iCite
Revised in PubMed
2026-03-16
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang MMengnan
2Preckel BBenedikt
3Zuurbier CJCoert J
4Weber NCNina Chttps://orcid.org/0000-0003-1111-9042

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Sodium-Glucose Transporter 2 InhibitorsMajor topic
Heart FailureMajor topic
Endothelium, VascularMajor topic
Ion ChannelsMajor topic
Endothelial CellsMajor topic
Humans
Animals

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
202208130005Chinese Government ScholarshipPubMed
4458Amsterdams UniversiteitsfondsPubMed

Source PubMed

Download CSV of grants

References189

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111698234Micromolar Ca(2+) from sparks activates Ca(2+)-sensitive K(+) channels in rat cerebral artery smooth muscle.Am J Physiol Cell Physiol2001https://conductscience.org/library/papers/11698234PubMed
234649282
Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.
Eur Heart J2021https://conductscience.org/library/papers/34649282PubMed
331500313Vascular Endothelial Cell Biology: An Update.Int J Mol Sci2019https://conductscience.org/library/papers/31500313PubMed
439571673Empagliflozin prevents TNF-α induced endothelial dysfunction under flow -the potential involvement of calcium and sodium-hydrogen exchanger.Eur J Pharmacol2025https://conductscience.org/library/papers/39571673PubMed
538520086Heart failure care in the Central and Eastern Europe and Baltic region: status, barriers, and routes to improvement.ESC Heart Fail2024https://conductscience.org/library/papers/38520086PubMed
632008372Local Peroxynitrite Impairs Endothelial Transient Receptor Potential Vanilloid 4 Channels and Elevates Blood Pressure in Obesity.Circulation2020https://conductscience.org/library/papers/32008372PubMed
738928371Hypertension and Heart Failure: From Pathophysiology to Treatment.Int J Mol Sci2024https://conductscience.org/library/papers/38928371PubMed
816467502Role of potassium in regulating blood flow and blood pressure.Am J Physiol Regul Integr Comp Physiol2006https://conductscience.org/library/papers/16467502PubMed
938118414Dapagliflozin protects against chronic heart failure in mice by inhibiting macrophage-mediated inflammation, independent of SGLT2.Cell Rep Med2023https://conductscience.org/library/papers/38118414PubMed
1038061206Empagliflozin prevents oxidative stress in human coronary artery endothelial cells via the NHE/PKC/NOX axis.Redox Biol2024https://conductscience.org/library/papers/38061206PubMed
1126724178Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.Lancet2016https://conductscience.org/library/papers/26724178PubMed
1239922424Sodium-glucose cotransporter 2 inhibitor empagliflozin enhances autophagy and reverses remodeling in hearts with large, old myocardial infarctions.Eur J Pharmacol2025https://conductscience.org/library/papers/39922424PubMed
13353634992022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.Circulation2022https://conductscience.org/library/papers/35363499PubMed
1412482889Freshly isolated bovine coronary endothelial cells do not express the BK Ca channel gene.J Physiol2002https://conductscience.org/library/papers/12482889PubMed
1527872234
Downregulation of Endothelial Transient Receptor Potential Vanilloid Type 4 Channel and Small-Conductance of Ca2+-Activated K+ Channels Underpins Impaired Endothelium-Dependent Hyperpolarization in Hypertension.
Hypertension2017https://conductscience.org/library/papers/27872234PubMed
1639739876SGLT2 expression in human vasculature and heart correlates with low-grade inflammation and causes eNOS-NO/ROS imbalance.Cardiovasc Res2025https://conductscience.org/library/papers/39739876PubMed
1711356638NHE and ICAM-1 expression in hypoxic/reoxygenated coronary microvascular endothelial cells.Am J Physiol Heart Circ Physiol2001https://conductscience.org/library/papers/11356638PubMed
1837504285The Role of the Piezo1 Mechanosensitive Channel in Heart Failure.Curr Issues Mol Biol2023https://conductscience.org/library/papers/37504285PubMed
1930194266Piezo1 and Gq/G11 promote endothelial inflammation depending on flow pattern and integrin activation.J Exp Med2018https://conductscience.org/library/papers/30194266PubMed
2025488697Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus.Drugs2015https://conductscience.org/library/papers/25488697PubMed

See all 189 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
42978803Complex antiarrhythmic effects of empagliflozin in non-ischemic HFrEF cardiomyocytes.Front Pharmacol2026https://conductscience.org/library/papers/42978803PubMed
42368857Molecular Interplay between hypertension and dyslipidemia in cardiovascular pathogenesis: toward precision-based therapeutic strategies.Front Cardiovasc Med2026https://conductscience.org/library/papers/42368857PubMed
42318351Empagliflozin-pirfenidone dual therapy improves cardiac function and structure in a preclinical two-hit HFpEF model.Front Pharmacol2026https://conductscience.org/library/papers/42318351PubMed
42168622Empagliflozin restores cardiac function in obese-diabetic HFpEF mice but further alters gene expression.Basic Res Cardiol2026https://conductscience.org/library/papers/42168622PubMed
42148365GBVAM as a Novel NHE1 Inhibitor Alleviates Doxorubicin-Induced Cardiotoxicity via PI3K/Akt/mTOR Pathway.Drug Des Devel Ther2026https://conductscience.org/library/papers/42148365PubMed
42110178Mechanisms and Therapeutic Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure.Rev Cardiovasc Med2026https://conductscience.org/library/papers/42110178PubMed
41995817Empagliflozin improves metabolism and prevents myocardial and coronary dysfunction in streptozotocin-diabetic and non-diabetic rats subjected to ischemia/reperfusion.Basic Res Cardiol2026https://conductscience.org/library/papers/41995817PubMed
41487902SGLT2 inhibitors in hemodialysis or peritoneal dialysis patients: rationale and state-of-the art.Clin Kidney J2026https://conductscience.org/library/papers/41487902PubMed
41393541Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors in Atrial Fibrillation: Clinical Implications, Mechanisms, and Therapeutic Potential.Cureus2025https://conductscience.org/library/papers/41393541PubMed
41392285SGLT2 inhibitors in cardiac amyloidosis: mechanistic insights and clinical perspectives-a narrative review.Cardiovasc Diabetol Endocrinol Rep2025https://conductscience.org/library/papers/41392285PubMed
41375659Metabolic Predictors of CAD: Focus on Cystine, Methionine, Proline, and Threonine Circulating Levels-Exploratory Pilot Study.J Clin Med2025https://conductscience.org/library/papers/41375659PubMed
41366613
Dapagliflozin Reduces Ambulatory Arterial Stiffness Index in CKD Patients with and Without Diabetes Independently of Blood Pressure Control: Results from the GLUcose Transport and Renal PROtection in Chronic Kidney Disease (GLUTREPRO) Trial.
High Blood Press Cardiovasc Prev2026https://conductscience.org/library/papers/41366613PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
SLC24A357419PubTator's text mininghttps://conductscience.org/library/genes/57419NCBI Gene
SLC9A16548PubTator's text mininghttps://conductscience.org/library/genes/6548NCBI Gene
TLX23196PubTator's text mininghttps://conductscience.org/library/genes/3196NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40366385

GET https://conductscience.org/api/papers/v1/40366385/references?page=2